title: Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin.
abstract: In patients with heart transplant, the combined determination of serum beta 2-microglobulin and urinary neopterin, as rejection marker, prevented the interference by renal function and cyclosporin therapy. Unfortunately, the simultaneous measurement of these two parameters cannot distinguish between a rejection episode and the early stage of viral infection.
authors.affiliation: Laboratoire de Biochimie, Hôpital Broussais, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Schmitt
authors.forename: I
authors.initials: I
authors.lastname: Myara
authors.forename: M O
authors.initials: MO
authors.lastname: Benoit
authors.forename: R
authors.initials: R
authors.lastname: Guillemain
authors.forename: C
authors.initials: C
authors.lastname: Amrein
authors.forename: G
authors.initials: G
authors.lastname: Dreyfus
authors.forename: M
authors.initials: M
authors.lastname: Paris
authors.forename: N
authors.initials: N
authors.lastname: Moatti
mesh_terms: D001708:Biopterins / Q000031:analogs & derivatives* / Q000652:urine; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D019798:Neopterin; D001613:beta 2-Microglobulin / Q000032:analysis*
chemical_list: D001613:beta 2-Microglobulin; D001708:Biopterins; D019798:Neopterin; D003404:Creatinine